{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:03:01Z","timestamp":1785416581762,"version":"3.56.0"},"reference-count":47,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2020 Qinghai Provincial Health Commission Guiding Topic","award":["2020-wjzdx-01"],"award-info":[{"award-number":["2020-wjzdx-01"]}]},{"name":"Qinghai Province \u201cKunlun Talents High-end Innovative and Entrepreneurial Talents\u201d cultivate top-notch talent","award":["QHKLYC-GDCXCY-2024-130"],"award-info":[{"award-number":["QHKLYC-GDCXCY-2024-130"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:Sepsis is characterized by profound immune dysregulation, in which myeloid-derived suppressor cells (MDSCs) serve as key regulators of the host immune response. However, the prognostic significance of distinct MDSC subsets during the early phase of sepsis remains incompletely understood.Methods:In this prospective cohort study, flow cytometry was used to quantify circulating MDSC subsets in sepsis patients within 24 hours of intensive care unit (ICU) admission and in healthy control subjects. Patients were followed to establish 90-day survival, and the prognostic significance of MDSC subset frequencies on admission was evaluated using receiver operating characteristic (ROC) curve analysis and Cox regression models. Multivariate Cox models were adjusted for disease severity scores. A murine cecal ligation and puncture (CLP) model of sepsis was also used to investigate temporal and tissue-specific MDSC dynamics and to examine endoplasmic reticulum (ER) stress-related signaling within these cells.Results:Compared with healthy controls, patients with sepsis exhibited the marked expansion of circulating MDSCs, including both polymorphonuclear and monocytic subsets. Among these, the proportion of circulating monocytic MDSCs (M-MDSCs) on ICU admission was significantly higher in 90-day survivors than in non-survivors. After adjusting for disease severity and other clinical variables, higher M-MDSC frequencies were independently associated with lower 90-day mortality. ROC curves confirmed the ability of the M-MDSC proportion to predict 90-day mortality. In the CLP model, MDSC subsets displayed temporal and tissue-specific dynamics that differed between the acute and recovery phases of sepsis. MDSCs isolated from septic mice exhibited ER stress-related pathway activation in the spleen and bone marrow. Collectively, these findings suggest that early M-MDSC expansion represents a distinct immunological phenotype associated with favorable outcomes in sepsis.Conclusions:An early increase in circulating M-MDSCs is associated with improved 90-day survival in patients with sepsis. These findings underscore the dynamic, context-dependent role of M-MDSCs in sepsis, indicating that early immunoregulatory responses, possibly associated with activation of ER stress pathways, may represent an adaptive mechanism leading to favorable clinical outcomes.<\/jats:p>","DOI":"10.31083\/fbl50593","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:17:49Z","timestamp":1785413869000},"source":"Crossref","is-referenced-by-count":0,"title":["Early Expansion of Monocytic Myeloid-Derived Suppressor Cells Predicts Survival in Sepsis and Is Possibly Associated With Activation of Endoplasmic Reticulum Stress Pathways"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0799-0682","authenticated-orcid":true,"given":"Juanli","family":"Liu","sequence":"first","affiliation":[{"name":"Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Laboratory for High Altitude Medicine), Qinghai University, 81000 Xining, Qinghai, China"},{"name":"Department of Critical Care Medicine, Qinghai Provincial People\u2019s Hospital, 810000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2695-4737","authenticated-orcid":true,"given":"Tana","family":"Wuren","sequence":"additional","affiliation":[{"name":"Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Laboratory for High Altitude Medicine), Qinghai University, 81000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3456-1214","authenticated-orcid":true,"given":"Xiaoyan","family":"Song","sequence":"additional","affiliation":[{"name":"Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Laboratory for High Altitude Medicine), Qinghai University, 81000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8083-8286","authenticated-orcid":true,"given":"Xue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Qinghai University, 810000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-3938","authenticated-orcid":true,"given":"Siqing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Qinghai Provincial People\u2019s Hospital, 810000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4940-9697","authenticated-orcid":true,"given":"Rili","family":"Ge","sequence":"additional","affiliation":[{"name":"Research Center for High Altitude Medicine, Key Laboratory of High Altitude Medicine (Ministry of Education), Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province (Qinghai-Utah Joint Research Key Laboratory for High Altitude Medicine), Qinghai University, 81000 Xining, Qinghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315: 801\u2013810.","DOI":"10.1001\/jama.2016.0287"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Singer M, Angus DC, Annane D, Bauer M, Kalil AC, Klompas M, et al. Sepsis. Lancet. 2026; 407: 1276\u20131288.","DOI":"10.1016\/S0140-6736(25)02422-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395: 200\u2013211.","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Medicine. 2020; 46: 1552\u20131562.","DOI":"10.1007\/s00134-020-06151-x"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Willmann K, Moita LF. Physiologic disruption and metabolic reprogramming in infection and sepsis. Cell Metabolism. 2024; 36: 927\u2013946.","DOI":"10.1016\/j.cmet.2024.02.013"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature Reviews. Immunology. 2017; 17: 407\u2013420.","DOI":"10.1038\/nri.2017.36"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical Care Medicine. 1999; 27: 1230\u20131251.","DOI":"10.1097\/00003246-199907000-00002"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Monneret G, Lepape A, Voirin N, Boh\u00e9 J, Venet F, Debard AL, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Medicine. 2006; 32: 1175\u20131183.","DOI":"10.1007\/s00134-006-0204-8"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal of Respiratory and Critical Care Medicine. 2009; 180: 640\u2013648.","DOI":"10.1164\/rccm.200903-0363OC"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Lin Y, Liu L, Liu Y, Yang R, Liao S, Xu M, et al. MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience (Landmark Edition). 2024; 29: 44.","DOI":"10.31083\/j.fbl2901044"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011; 306: 2594\u20132605.","DOI":"10.1001\/jama.2011.1829"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. The Lancet. Infectious Diseases. 2013; 13: 260\u2013268.","DOI":"10.1016\/S1473-3099(13)70001-X"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews. Immunology. 2009; 9: 162\u2013174.","DOI":"10.1038\/nri2506"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nature Reviews. Immunology. 2021; 21: 485\u2013498.","DOI":"10.1038\/s41577-020-00490-y"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature Communications. 2016; 7: 12150.","DOI":"10.1038\/ncomms12150"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Research. 2009; 69: 1553\u20131560.","DOI":"10.1158\/0008-5472.CAN-08-1921"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends in Immunology. 2003; 24: 302\u2013306.","DOI":"10.1016\/s1471-4906(03)00132-7"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Rastad JL, Green WR. Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-\u03b2. Virology. 2016; 499: 9\u201322.","DOI":"10.1016\/j.virol.2016.08.031"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"He YM, Li X, Perego M, Nefedova Y, Kossenkov AV, Jensen EA, et al. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nature Medicine. 2018; 24: 224\u2013231.","DOI":"10.1038\/nm.4467"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Tebartz C, Horst SA, Sparwasser T, Huehn J, Beineke A, Peters G, et al. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. Journal of Immunology. 2015; 194: 1100\u20131111.","DOI":"10.4049\/jimmunol.1400196"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Heim CE, Vidlak D, Scherr TD, Kozel JA, Holzapfel M, Muirhead DE, et al. Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. Journal of Immunology. 2014; 192: 3778\u20133792.","DOI":"10.4049\/jimmunol.1303408"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Zhang C, Lei GS, Shao S, Jung HW, Durant PJ, Lee CH. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infection and Immunity. 2012; 80: 3634\u20133641.","DOI":"10.1128\/IAI.00668-12"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, M\u00fcller M, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. The Journal of Experimental Medicine. 2010; 207: 1453\u20131464.","DOI":"10.1084\/jem.20091474"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Mathias B, Delmas AL, Ozrazgat-Baslanti T, Vanzant EL, Szpila BE, Mohr AM, et al. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis\/Septic Shock. Annals of Surgery. 2017; 265: 827\u2013834.","DOI":"10.1097\/SLA.0000000000001783"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Waeckel L, Venet F, Gossez M, Monard C, Rimmel\u00e9 T, Monneret G. Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study. Critical Care. 2020; 24: 132.","DOI":"10.1186\/s13054-020-02857-y"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hollen MK, Stortz JA, Darden D, Dirain ML, Nacionales DC, Hawkins RB, et al. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis. Critical Care. 2019; 23: 355.","DOI":"10.1186\/s13054-019-2628-x"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Schrijver IT, Karakike E, Th\u00e9roude C, Baumgartner P, Harari A, Giamarellos-Bourboulis EJ, et al. High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure. Intensive Care Medicine Experimental. 2022; 10: 5.","DOI":"10.1186\/s40635-022-00431-0"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Brudecki L, Ferguson DA, McCall CE, El Gazzar M. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infection and Immunity. 2012; 80: 2026\u20132034.","DOI":"10.1128\/IAI.00239-12"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Molecular Medicine. 2011; 17: 281\u2013292.","DOI":"10.2119\/molmed.2010.00178"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Janols H, Bergenfelz C, Allaoui R, Larsson AM, Ryd\u00e9n L, Bj\u00f6rnsson S, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. Journal of Leukocyte Biology. 2014; 96: 685\u2013693.","DOI":"10.1189\/jlb.5HI0214-074R"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"van der Poll T. Myeloid-derived Suppressor Cells in Sepsis. American Journal of Respiratory and Critical Care Medicine. 2017; 196: 256\u2013258.","DOI":"10.1164\/rccm.201701-0046ED"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nature Reviews. Immunology. 2016; 16: 469\u2013484.","DOI":"10.1038\/nri.2016.62"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011; 334: 1081\u20131086.","DOI":"10.1126\/science.1209038"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell. 2015; 161: 1527\u20131538.","DOI":"10.1016\/j.cell.2015.05.025"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols. 2009; 4: 31\u201336.","DOI":"10.1038\/nprot.2008.214"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Autengruber A, Gereke M, Hansen G, Hennig C, Bruder D. Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. European Journal of Microbiology & Immunology. 2012; 2: 112\u2013120.","DOI":"10.1556\/EuJMI.2.2012.2.3"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Critical Care Medicine. 1996; 24: 1125\u20131128.","DOI":"10.1097\/00003246-199607000-00010"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine\/inhibitor profiles reshape the understanding of the SIRS\/CARS continuum in sepsis and predict mortality. Journal of Immunology. 2006; 177: 1967\u20131974.","DOI":"10.4049\/jimmunol.177.3.1967"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Zhu B, Wang J, Wang Y. Multi-omics Analysis Reveals Molecular Subtype of Mitochondrial Oxidative Stress and Prognostic Model Development in Sepsis. Frontiers in Bioscience (Landmark Edition). 2025; 30: 38957.","DOI":"10.31083\/fbl38957"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nature Immunology. 2018; 19: 108\u2013119.","DOI":"10.1038\/s41590-017-0022-x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduction and Targeted Therapy. 2022; 7: 218.","DOI":"10.1038\/s41392-022-01080-1"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Di Conza G, Ho PC, Cubillos-Ruiz JR, Huang SCC. Control of immune cell function by the unfolded protein response. Nature Reviews. Immunology. 2023; 23: 546\u2013562.","DOI":"10.1038\/s41577-023-00838-0"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Cl\u00e1udio N, Dalet A, Gatti E, Pierre P. Mapping the crossroads of immune activation and cellular stress response pathways. The EMBO Journal. 2013; 32: 1214\u20131224.","DOI":"10.1038\/emboj.2013.80"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nature Reviews. Molecular Cell Biology. 2020; 21: 421\u2013438.","DOI":"10.1038\/s41580-020-0250-z"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Condamine T, Kumar V, Ramachandran IR, Youn JI, Celis E, Finnberg N, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. The Journal of Clinical Investigation. 2014; 124: 2626\u20132639.","DOI":"10.1172\/JCI74056"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Hetz C, Papa FR. The Unfolded Protein Response and Cell Fate Control. Molecular Cell. 2018; 69: 169\u2013181.","DOI":"10.1016\/j.molcel.2017.06.017"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer. Cell. 2017; 168: 692\u2013706.","DOI":"10.1016\/j.cell.2016.12.004"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL50593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:18:51Z","timestamp":1785413931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL50593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02178-7"],"URL":"https:\/\/doi.org\/10.31083\/fbl50593","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"50593"}}